Lipocine Inc.
Bioavailable solid state (17-.beta.)-hydroxy-4-androsten-3-one esters

Last updated:

Abstract:

Disclosed are bioavailable solid state (17-.beta.)-Hydroxy-4-Androsten-3-one esters suitable for pharmaceutical uses and administration to mammals in need of (17-.beta.)-Hydroxy-4-Androsten-3-one.

Status:
Grant
Type:

Utility

Filling date:

15 Apr 2020

Issue date:

12 Apr 2022